Upregulated TUG1 exerts its potential effects on ESCC manifestation through enhancing Wnt/β-catenin pathway-associated protein markers, such as Wnt1, c-Myc, cyclinD1, and β-catenin [15] (Figure 4). This evidence concerns the gene TUG1 and esophageal squamous cell carcinoma.